Precision Medicine

precision medicine survey
By Bill Siwicki 08:55 am April 03, 2017
Precision medicine holds the promise of combatting diseases in whole new ways, but the barrier to entry is pretty high.
NantHealth Patrick Soon-Shiong
By Jessica Davis 01:37 pm March 31, 2017
Lack of sales from its GPC Cancer diagnostic test dragged down finances as the company continues to face public scrutiny.

Andrew Pecora, MD

By Mike Miliard 11:09 am March 27, 2017
The multi-year research agreement will see the pharmaceutical company putting Cota's analytics platform to work for improved breast cancer treatment outcomes.
Intermountain predicting chronic disease

Heidi May, cardiovascular epidemiologist at the Intermountain Medical Center Heart Institute, led research into the predictors of chronic illnesses.

By Bernie Monegain 02:14 pm March 20, 2017
Researchers say the Intermountain Chronic Disease Risk Score can predict which patients will receive a first diagnosis within three years.
Intel artificial intelligence cancer
By Jack McCarthy 09:39 am March 16, 2017
Company officials said the competition offers a total of $100,000 for three winners, with first place taking $50,000. 
By Jessica Davis 05:18 pm March 14, 2017
Two Advisory Board research leaders discuss the current state of precision medicine – and what it will take for genomics to become part of routine care.
genomics patient generated health data
By Jack McCarthy 09:42 am March 13, 2017
The lack of adequate EHR interoperability continues to hinder healthcare organizations ability to use patient data in care delivery, the report’s author said. 
NantHealth Soon-Shiong

Patrick Soon-Shiong, MD

By Jessica Davis 11:51 am March 09, 2017
A single investor is suing the biotech mogul and NantHealth, alleging violation of federal securities laws. Other law firms have also filed class action suits against the company.

Patrick Soon-Shiong, MD, speaking at HIMSS17 in February.

By Jessica Davis 10:34 am March 07, 2017
The report claims the biotech mogul used charitable donations to benefit his health tech company.
Linguamatics, Varian Medical Systems
By Bill Siwicki 09:18 am February 27, 2017
Varian will use the Linguamatics Health platform to extract unstructured concepts from within pathology reports and convert them to discrete data for analytics within Varian 360 Oncology.  

Most Read

The Daily Brief Newsletter